当前位置: X-MOL 学术J. Hematol. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction: Non-invasive diagnosis of esophageal cancer by a simplified circulating cell-free DNA methylation assay targeting OTOP2 and KCNA3: a double-blinded, multicenter, prospective study
Journal of Hematology & Oncology ( IF 29.5 ) Pub Date : 2024-12-21 , DOI: 10.1186/s13045-024-01653-3
Yan Bian, Ye Gao, Han Lin, Chang Sun, Wei Wang, Siyu Sun, Xiuling Li, Zhijie Feng, Jianlin Ren, Hezhong Chen, Chaojing Lu, Jinfang Xu, Jun Zhou, Kangkang Wan, Lei Xin, Zhaoshen Li, Luowei Wang

Correction : Journal of Hematology & Oncology (2024) 17:47 https://doi.org/10.1186/s13045-024-01565-2

The original article erroneously presents a duplicate of Figure 2A over Figure 2B. The corrected Figure 2 with correct Figure 2B can be viewed ahead in this Correction article.

Fig. 2
figure 2

A Ct values of plasma methylated OTOP2 for the participants. B Ct values of plasma methylated KCNA3 for the participants. C ROC for OTOP2, KCNA3, or either for all patients with EC versus all controls. D ROC for OTOP2, KCNA3, or either for patients with HGIN versus all controls. E ROC for OTOP2, KCNA3, or either for patients with stage I EC versus all controls. F ROC for OTOP2, KCNA3, or either for patients with stage II EC versus all controls. G ROC for OTOP2, KCNA3, or either for patients with stage III EC versus all controls. H ROC for OTOP2, KCNA3, or either for patients with stage IV EC versus all controls. I The proportion of positive results for OTOP2, KCNA3, or either, in all patients with EC and patients with HGIN, stage I, stage II, stage III, and stage IV EC. J The proportion of positive results for OTOP2, KCNA3, or either, in all controls, HC, and patients with BL, DSM, and non-DSM. Either of KCNA3 and OTOP2 positive was defined as positive, and both negative was defined as negative. K Ct value of plasma methylated OTOP2 in patients with EC before and one day after surgery. L Ct value of plasma methylated KCNA3 in patients with EC before and one day after surgery. M Annular heatmap of the result of combining OTOP2 and KCNA3 in paired plasma samples from before and one day after surgery from the same patients with EC. Black horizontal lines are median and error bars are interquartile range. Ct = cycle threshold. ROC = the receiver operating characteristics curve. EC = esophageal cancer. ESCC = esophageal squamous cell carcinoma. EAC = esophageal adenocarcinoma. HGIN = high-grade intraepithelial neoplasia. HC = healthy control. BL = benign lesion. DSM = digestive system malignancy. P = patient

Full size image
Author notes
  1. Yan Bian, Ye Gao, Han Lin and Chang Sun contributed equally to this work.

Authors and Affiliations

  1. Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China

    Yan Bian, Ye Gao, Han Lin, Chang Sun, Wei Wang, Lei Xin, Zhaoshen Li & Luowei Wang

  2. Changhai Clinical Research Unit, Changhai Hospital, Naval Medical University, Shanghai, China

    Yan Bian, Ye Gao, Han Lin, Chang Sun, Wei Wang, Lei Xin, Zhaoshen Li & Luowei Wang

  3. National Key Laboratory of Immunity and Inflammation, Naval Medical University, Shanghai, China

    Yan Bian, Ye Gao, Chang Sun, Lei Xin, Zhaoshen Li & Luowei Wang

  4. Department of Gastroenterology, Shengjing Hospital, China Medical University, Shenyang, Liaoning, China

    Siyu Sun

  5. Department of Gastroenterology, Henan Provincial People’s Hospital, Zhengzhou, Henan, China

    Xiuling Li

  6. Department of Gastroenterology, The Second Hospital of Hebei Medical University, Hebei Medical University, Shijiazhuang, Hebei, China

    Zhijie Feng

  7. Department of Gastroenterology, Zhongshan Hospital, Xiamen University, Xiamen, Fujian, China

    Jianlin Ren

  8. Department of Thoracic Surgery, Changhai Hospital, Naval Medical University, Shanghai, China

    Hezhong Chen & Chaojing Lu

  9. Department of Health Statistics, Naval Medical University, Shanghai, China

    Jinfang Xu

  10. Wuhan Ammunition Life-Tech Company, Ltd., Wuhan, Hubei, China

    Jun Zhou & Kangkang Wan

Authors
  1. Yan BianView author publications

    You can also search for this author in PubMed Google Scholar

  2. Ye GaoView author publications

    You can also search for this author in PubMed Google Scholar

  3. Han LinView author publications

    You can also search for this author in PubMed Google Scholar

  4. Chang SunView author publications

    You can also search for this author in PubMed Google Scholar

  5. Wei WangView author publications

    You can also search for this author in PubMed Google Scholar

  6. Siyu SunView author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiuling LiView author publications

    You can also search for this author in PubMed Google Scholar

  8. Zhijie FengView author publications

    You can also search for this author in PubMed Google Scholar

  9. Jianlin RenView author publications

    You can also search for this author in PubMed Google Scholar

  10. Hezhong ChenView author publications

    You can also search for this author in PubMed Google Scholar

  11. Chaojing LuView author publications

    You can also search for this author in PubMed Google Scholar

  12. Jinfang XuView author publications

    You can also search for this author in PubMed Google Scholar

  13. Jun ZhouView author publications

    You can also search for this author in PubMed Google Scholar

  14. Kangkang WanView author publications

    You can also search for this author in PubMed Google Scholar

  15. Lei XinView author publications

    You can also search for this author in PubMed Google Scholar

  16. Zhaoshen LiView author publications

    You can also search for this author in PubMed Google Scholar

  17. Luowei WangView author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Lei Xin, Zhaoshen Li or Luowei Wang.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bian, Y., Gao, Y., Lin, H. et al. Correction: Non-invasive diagnosis of esophageal cancer by a simplified circulating cell-free DNA methylation assay targeting OTOP2 and KCNA3: a double-blinded, multicenter, prospective study. J Hematol Oncol 17, 129 (2024). https://doi.org/10.1186/s13045-024-01653-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13045-024-01653-3

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

更新日期:2024-12-21
down
wechat
bug